These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29515254)

  • 1. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.
    El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R
    Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
    Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
    Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
    Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
    Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
    Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
    Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
    Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
    Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-independent proteasomal degradation of Spindlin-1 by the E3 ligase HACE1 contributes to cell-cell adhesion.
    Palicharla VR; Gupta D; Bhattacharya D; Maddika S
    FEBS Lett; 2021 Feb; 595(4):491-506. PubMed ID: 33421097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
    Kim I; Shin SH; Lee JE; Park JW
    Oncogene; 2019 May; 38(19):3651-3666. PubMed ID: 30659265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group-I PAKs-mediated phosphorylation of HACE1 at serine 385 regulates its oligomerization state and Rac1 ubiquitination.
    Acosta MI; Urbach S; Doye A; Ng YW; Boudeau J; Mettouchi A; Debant A; Manser E; Visvikis O; Lemichez E
    Sci Rep; 2018 Jan; 8(1):1410. PubMed ID: 29362425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HACE1 is a potential tumor suppressor in osteosarcoma.
    El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
    Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
    Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
    Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
    Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
    Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
    Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
    Nat Commun; 2013; 4():2180. PubMed ID: 23864022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitylation of active Rac1 by the E3 ubiquitin-ligase HACE1.
    Mettouchi A; Lemichez E
    Small GTPases; 2012; 3(2):102-6. PubMed ID: 22790197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination.
    Lee YS; Jung YY; Park MH; Yeo IJ; Im HS; Nam KT; Kim HD; Kang SK; Song JK; Kim YR; Choi DY; Park PH; Han SB; Yun JS; Hong JT
    Cancer Lett; 2018 Oct; 433():156-164. PubMed ID: 29981809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
    Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
    Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
    Goka ET; Lippman ME
    Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The tumor suppressor HACE1 targets Rac1 to ubiquitin-mediated proteasomal degradation].
    Gacon G; Mettouchi A; Lemichez E
    Med Sci (Paris); 2012 Jan; 28(1):39-41. PubMed ID: 22289828
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
    Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
    Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
    Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.